Professor Ian Charles

Professor Ian Charles is the Director of IFR and leads the programme to develop the UK’s new Quadram Institute, based at the Norwich Research Park.

Professor Charles returned to the UK in 2015 from Australia where he was Director of the ithree institute, University of Technology, Sydney.

He has over 30 years’ experience in academic and commercial research. His academic career has included being a founding member of The Wolfson Institute for Biomedical Research at University College London, one the UK’s first institutes of translational medicine. He has also worked in the pharmaceutical industry at Glaxo Wellcome, and has been founder and CSO of biotech companies in the area of infectious disease, including Arrow Therapeutics, sold to AstraZeneca, and Auspherix a venture capital backed company founded in 2013. His current research interests include infectious diseases as well as the microbiome and its impact on health and wellbeing.